NASDAQ : ENSG
The Ensign Group, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 181.52 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.50B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 10.50B |
| Enterprise Value | 12.40B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Sep 30, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 57.85M |
| Shares Outstanding | 57.85M |
| Shares Change (YoY) | +1.28% |
| Shares Change (QoQ) | -0.30% |
| Owned by Insiders (%) | 3.62% |
| Owned by Institutions (%) | 92.46% |
| Float | 55.70M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 27.02 |
| Forward PE | 21.11 |
| PS Ratio | 1.85 |
| Forward PS | 1.62 |
| PB Ratio | 4.10 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | 20.59 |
| P/OCF Ratio | 15.09 |
| PEG Ratio | 1.41 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 31.06 |
| EV / Sales | 2.18 |
| EV / EBITDA | 19.95 |
| EV / EBIT | 24.70 |
| EV / FCF | 24.31 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.20 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 2.51 |
| Debt / FCF | 4.49 |
| Interest Coverage | 61.92 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 17.05% |
| Return on Assets (ROA) | 5.59% |
| Return on Invested Capital (ROIC) | 8.53% |
| Return on Capital Employed (ROCE) | 9.97% |
| Weighted Average Cost of Capital (WACC) | 6.51% |
| Revenue Per Employee | $123,354 |
| Profits Per Employee | $8,677 |
| Employee Count | 46,000 |
| Asset Turnover | 1.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 133.02M |
| Effective Tax Rate | 24.98% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -0.65% |
| 50-Day Moving Average | 174.79 |
| 200-Day Moving Average | 181.64 |
| Relative Strength Index (RSI) | 55.94 |
| Average Volume (20 Days) | 390,398 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.39M |
| Short Previous Month | 1.48M |
| Short % of Shares Out | 2.41% |
| Short % of Float | 2.50% |
| Short Ratio (days to cover) | 3.85 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.67B |
| Gross Profit | 970.23M |
| Operating Income | 501.91M |
| Pretax Income | 532.53M |
| Net Income | 399.12M |
| EBITDA | 621.53M |
| EBIT | 501.91M |
| Earnings Per Share (EPS) | $6.72 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 391.69M |
| Total Debt | 2.29B |
| Net Cash | -1.90B |
| Net Cash Per Share | -$32.78 |
| Equity (Book Value) | 2.56B |
| Book Value Per Share | 44.24 |
| Working Capital | 191.97M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 695.67M |
| Capital Expenditures | -185.76M |
| Depreciation & Amortization | 119.61M |
| Net Borrowing | 55.81M |
| Free Cash Flow | 509.91M |
| FCF Per Share | $8.81 |
Margins
| Measure | Value |
|---|
| Gross Margin | 17.10% |
| Operating Margin | 8.85% |
| Pretax Margin | 9.38% |
| Profit Margin | 7.03% |
| EBITDA Margin | 10.95% |
| EBIT Margin | 8.85% |
| FCF Margin | 8.99% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.26 |
| Dividend Yield | 0.14% |
| Dividend Growth (YoY) | 4.00% |
| Years of Dividend Growth | 18 |
| Payout Ratio | 3.87% |
| FCF Payout Ratio | 2.95% |
| Buyback Yield | -1.28% |
| Shareholder Yield | -1.13% |
| Earnings Yield | 3.70% |
| FCF Yield | 4.86% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $223.60 |
| Price Target Difference | 23.18% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 12.68% |
| EPS Growth Forecast (3Y) | 13.37% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 24, 2015 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.57 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |